Eli Lilly Monoclonal Antibody Drug Prevents COVID Infections in Nursing Homes

<p>A study of nursing home residents found that a monoclonal antibody treatment made by Eli Lilly can cut the risk of Covid-19 by up to 80%. It is important to catch people at the early stages of infection and is meant for those that are high-risk patients. One of the difficulties in administering these drugs however is that it’s delivered via an hour-long infusion. Karen Weintruab, health reporter at USA Today, joins us for more.</p><p> </p> Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com">https://www.iheartpodcastnetwork.com</a><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>